|
Market Closed -
Nasdaq
16:00:00 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 119.02 USD | +0.78% |
|
+6.10% | +242.01% |
| 08-18 | Truist Adjusts Price Target on Corcept Therapeutics to $164 From $50, Maintains Buy Rating | MT |
| 07-29 | Corcept Therapeutics Incorporated, Q2 2026 Earnings Call, Jul 29, 2026 |
| Market Cap | 12.87B 11.04B 10.31B 9.46B 17.78B 1,230B 18.07B 122B 47.62B 617B 48.31B 47.26B 2,039B | P/E 2026 * |
57.8x | P/E 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 12.87B 11.04B 10.31B 9.46B 17.78B 1,230B 18.07B 122B 47.62B 617B 48.31B 47.26B 2,039B | EV / Sales 2026 * |
11.2x | EV / Sales 2027 * | 7.55x |
| Free-Float |
65.9% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Corcept Therapeutics Incorporated
| 1 day | +0.78% | ||
| 1 week | +6.10% | ||
| Current month | +3.96% | ||
| 1 month | +31.48% | ||
| 3 months | +104.43% | ||
| 6 months | +247.61% | ||
| Current year | +242.01% |
| 1 week | 110.08 | 121.11 | |
| 1 month | 90 | 122.21 | |
| Current year | 28.66 | 122.21 | |
| 1 year | 28.66 | 122.21 | |
| 3 years | 20.84 | 122.21 | |
| 5 years | 15.82 | 122.21 | |
| 10 years | 5.24 | 122.21 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
CEO | Chief Executive Officer | 68 | 1998-12-31 |
Atabak Mokari
DFI | Director of Finance/CFO | 49 | 2021-02-28 |
Joseph Lyon
CTO | Chief Tech/Sci/R&D Officer | 48 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Belanoff
BRD | Director/Board Member | 68 | 1998-12-31 |
James Wilson
CHM | Chairman | 82 | 1998-12-31 |
David Mahoney
BRD | Director/Board Member | 71 | 2004-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/12/26 | Don | Company Secretary | -17,530 | 0.0162% | ||
| 8/10/26 | Fiscal year | Executive/Senior Manager | 3,093 | 0.0029% | ||
| 8/10/26 | Fiscal year | Executive/Senior Manager | 48,900 | 0.0452% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.78% | +6.10% | +69.57% | +284.80% | 12.77B | ||
| +4.46% | +4.92% | +82.07% | +134.31% | 1,093B | ||
| +0.85% | +4.81% | +53.77% | +58.51% | 653B | ||
| +2.72% | +6.92% | +28.99% | +77.15% | 458B | ||
| +1.80% | +0.52% | +41.20% | +44.05% | 355B | ||
| +1.24% | +2.35% | +25.99% | +42.21% | 294B | ||
| +2.07% | +2.97% | +2.27% | +13.06% | 248B | ||
| +4.02% | +6.29% | +49.67% | +68.96% | 230B | ||
| +1.05% | -0.02% | -13.96% | -52.13% | 203B | ||
| +2.90% | +8.63% | +25.11% | +94.52% | 178B | ||
| Average | +1.81% | +3.42% | +36.47% | +76.54% | 372.32B | |
| Weighted average by Cap. | +1.53% | +3.66% | +46.95% | +74.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.15B 983M 918M 842M 1.58B 110B 1.61B 10.83B 4.24B 54.94B 4.3B 4.21B 182B | 1.7B 1.46B 1.37B 1.25B 2.36B 163B 2.39B 16.11B 6.31B 81.73B 6.4B 6.26B 270B |
| Net income | 242M 207M 193M 178M 334M 23.09B 339M 2.28B 894M 11.58B 907M 887M 38.28B | 594M 509M 475M 436M 820M 56.74B 834M 5.61B 2.2B 28.46B 2.23B 2.18B 94.09B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-19 | US$119.02 | +0.78% | 859,630 |
| 26-08-18 | US$118.10 | +0.79% | 804,025 |
| 26-08-17 | US$117.17 | +2.36% | 541,103 |
| 26-08-14 | US$114.47 | +3.58% | 728,923 |
| 26-08-13 | US$110.51 | -1.49% | 740,456 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CORT Stock
Select your edition
All financial news and data tailored to specific country editions

















